,date,title,url
0,2017-08-04,大参林股票交易异常波动公告,/disclosure/listedinfo/announcement/c/2017-08-04/603233_20170804_1.pdf
1,2017-08-04,大参林：关于《大参林医药集团股份有限公司股票交易异常波动问询函》的回复,/disclosure/listedinfo/announcement/c/2017-08-04/603233_20170804_2.pdf
2,2017-08-05,大参林关于签订募集资金专户存储三方监管协议的公告,/disclosure/listedinfo/announcement/c/2017-08-05/603233_20170805_1.pdf
3,2017-08-05,大参林：募集资金专户存储三方监管协议,/disclosure/listedinfo/announcement/c/2017-08-05/603233_20170805_2.pdf
4,2017-08-29,大参林关于修订公司章程的公告,/disclosure/listedinfo/announcement/c/2017-08-29/603233_20170829_8.pdf
5,2017-08-29,大参林关于使用部分闲置自有资金购买理财产品的公告,/disclosure/listedinfo/announcement/c/2017-08-29/603233_20170829_7.pdf
6,2017-08-29,大参林关于会计政策变更的公告,/disclosure/listedinfo/announcement/c/2017-08-29/603233_20170829_6.pdf
7,2017-08-29,大参林公司章程,/disclosure/listedinfo/announcement/c/2017-08-29/603233_20170829_9.pdf
8,2017-08-29,大参林独立董事关于第二届董事会第十次会议事项的独立意见,/disclosure/listedinfo/announcement/c/2017-08-29/603233_20170829_5.pdf
9,2017-08-29,大参林第二届监事会第四次会议决议,/disclosure/listedinfo/announcement/c/2017-08-29/603233_20170829_10.pdf
10,2017-08-29,大参林第二届董事会第十次会议决议,/disclosure/listedinfo/announcement/c/2017-08-29/603233_20170829_4.pdf
11,2017-08-29,大参林2017年半年度报告摘要,/disclosure/listedinfo/announcement/c/2017-08-29/603233_2017_zzy.pdf
12,2017-08-29,大参林2017年半年度报告,/disclosure/listedinfo/announcement/c/2017-08-29/603233_2017_z.pdf
13,2017-08-30,大参林关于修订《公司章程》的公告,/disclosure/listedinfo/announcement/c/2017-08-30/603233_20170830_1.pdf
14,2017-08-30,大参林关于使用部分闲置自有资金购买理财产品的公告,/disclosure/listedinfo/announcement/c/2017-08-30/603233_20170830_3.pdf
15,2017-08-30,大参林关于会计政策变更的公告,/disclosure/listedinfo/announcement/c/2017-08-30/603233_20170830_2.pdf
16,2017-09-20,大参林关于使用募集资金置换预先投入募投项目的自筹资金的公告,/disclosure/listedinfo/announcement/c/2017-09-20/603233_20170920_1.pdf
17,2017-09-20,大参林独立董事关于第二届董事会第十一次会议发表的独立意见,/disclosure/listedinfo/announcement/c/2017-09-20/603233_20170920_2.pdf
18,2017-09-20,大参林第二届监事会第五次会议决议的公告,/disclosure/listedinfo/announcement/c/2017-09-20/603233_20170920_6.pdf
19,2017-09-20,大参林第二届董事会第十一次会议决议的公告,/disclosure/listedinfo/announcement/c/2017-09-20/603233_20170920_5.pdf
20,2017-09-20,大参林：中信建投证券股份有限公司关于大参林医药集团股份有限公司使用募集资金置换预先投入募投项目的自筹资金的核查意见,/disclosure/listedinfo/announcement/c/2017-09-20/603233_20170920_3.pdf
21,2017-09-20,大参林：关于大参林医药集团股份有限公司以自筹资金预先投入募投项目的鉴证报告,/disclosure/listedinfo/announcement/c/2017-09-20/603233_20170920_4.pdf
22,2017-09-21,大参林关于使用募集资金置换预先投入募投项目的自筹资金公告的更正公告,/disclosure/listedinfo/announcement/c/2017-09-21/603233_20170921_2.pdf
23,2017-09-21,大参林第二届董事会第十一次会议决议公告的更正公告,/disclosure/listedinfo/announcement/c/2017-09-21/603233_20170921_1.pdf
24,2017-09-22,大参林关于使用募集资金置换预先投入募投项目的自筹资金公告的更正公告的补充公告,/disclosure/listedinfo/announcement/c/2017-09-22/603233_20170922_3.pdf
25,2017-09-22,大参林：中信建投证券股份有限公司关于大参林医药集团股份有限公司使用募集资金置换预先投入募投项目的自筹资金的核查意见,/disclosure/listedinfo/announcement/c/2017-09-22/603233_20170922_4.pdf
26,2017-09-27,大参林《关于使用募集资金置换预先投入募投项目的自筹资金的公告》的再次补充公告,/disclosure/listedinfo/announcement/c/2017-09-27/603233_20170927_1.pdf
27,2017-09-28,大参林关于使用闲置自有资金购买理财产品的进展公告,/disclosure/listedinfo/announcement/c/2017-09-28/603233_20170928_1.pdf
28,2017-10-21,大参林关于使用闲置自有资金购买理财产品的进展公告,/disclosure/listedinfo/announcement/c/2017-10-21/603233_20171021_1.pdf
29,2017-10-27,大参林关于使用部分闲置募集资金购买理财产品的公告,/disclosure/listedinfo/announcement/c/2017-10-27/603233_20171027_5.pdf
30,2017-10-27,大参林第二届监事会第六次会议决议公告,/disclosure/listedinfo/announcement/c/2017-10-27/603233_20171027_4.pdf
31,2017-10-27,大参林第二届董事会第十二次会议决议公告,/disclosure/listedinfo/announcement/c/2017-10-27/603233_20171027_3.pdf
32,2017-10-27,大参林：中信建投证券股份有限公司关于大参林医药集团股份有限公司使用闲置募集资金购买理财产品的核查意见,/disclosure/listedinfo/announcement/c/2017-10-27/603233_20171027_6.pdf
33,2017-10-27,大参林2017年第三季度报告,/disclosure/listedinfo/announcement/c/2017-10-27/603233_2017_3.pdf
34,2017-11-02,大参林关于使用闲置自有资金购买理财产品的进展公告,/disclosure/listedinfo/announcement/c/2017-11-02/603233_20171102_2.pdf
35,2017-11-02,大参林关于使用部分闲置募集资金购买理财产品的进展公告,/disclosure/listedinfo/announcement/c/2017-11-02/603233_20171102_1.pdf
36,2017-11-04,大参林关于收购福建省国晟医药连锁有限公司相关资产及股权的公告,/disclosure/listedinfo/announcement/c/2017-11-04/603233_20171104_1.pdf
37,2017-11-04,大参林第二届监事会第七次会议决议公告,/disclosure/listedinfo/announcement/c/2017-11-04/603233_20171104_2.pdf
38,2017-11-07,大参林关于收购福建省国晟医药连锁有限公司相关资产及股权的补充公告,/disclosure/listedinfo/announcement/c/2017-11-07/603233_20171107_1.pdf
39,2017-12-14,大参林可转换公司债券持有人会议规则（2017年12月）,/disclosure/listedinfo/announcement/c/2017-12-14/603233_20171214_18.pdf
40,2017-12-14,大参林关于最近五年未被证券监管部门和交易所采取监管措施或处罚的公告,/disclosure/listedinfo/announcement/c/2017-12-14/603233_20171214_22.pdf
41,2017-12-14,大参林关于召开2018年第一次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2017-12-14/603233_20171214_25.pdf
42,2017-12-14,大参林关于修订《公司章程》的公告,/disclosure/listedinfo/announcement/c/2017-12-14/603233_20171214_26.pdf
43,2017-12-14,大参林关于全体董事、高级管理人员、控股股东及实际控制人对公司公开发行可转换公司债券摊薄即期回报采取填补措施的承诺的公告,/disclosure/listedinfo/announcement/c/2017-12-14/603233_20171214_21.pdf
44,2017-12-14,大参林关于前次募集资金使用情况报告的公告,/disclosure/listedinfo/announcement/c/2017-12-14/603233_20171214_28.pdf
45,2017-12-14,大参林关于公司拟购买土地使用权的公告,/disclosure/listedinfo/announcement/c/2017-12-14/603233_20171214_27.pdf
46,2017-12-14,大参林关于公开发行可转换公司债券预案的公告,/disclosure/listedinfo/announcement/c/2017-12-14/603233_20171214_15.pdf
47,2017-12-14,大参林关于公开发行可转换公司债券摊薄即期回报及采取填补措施的公告,/disclosure/listedinfo/announcement/c/2017-12-14/603233_20171214_20.pdf
48,2017-12-14,大参林关于公开发行可转换公司债券募集资金运用的可行性分析报告,/disclosure/listedinfo/announcement/c/2017-12-14/603233_20171214_16.pdf
49,2017-12-14,大参林关于公开发行A股可转换公司债券的独立董事意见函,/disclosure/listedinfo/announcement/c/2017-12-14/603233_20171214_19.pdf
50,2017-12-14,大参林第二届监事会第八次会议决议公告,/disclosure/listedinfo/announcement/c/2017-12-14/603233_20171214_24.pdf
51,2017-12-14,大参林第二届董事会第十四次会议决议公告,/disclosure/listedinfo/announcement/c/2017-12-14/603233_20171214_23.pdf
52,2017-12-14,大参林：前次募集资金使用情况鉴证报告,/disclosure/listedinfo/announcement/c/2017-12-14/603233_20171214_17.pdf
53,2017-12-15,大参林关于使用部分闲置募集资金购买理财产品的进展公告,/disclosure/listedinfo/announcement/c/2017-12-15/603233_20171215_2.pdf
54,2017-12-23,大参林2018年第一次临时股东大会会议材料,/disclosure/listedinfo/announcement/c/2017-12-23/603233_20171223_1.pdf
55,2017-12-29,大参林：中信建投证券股份有限公司关于大参林医药集团股份有限公司2017年度持续督导工作现场检查报告,/disclosure/listedinfo/announcement/c/2017-12-29/603233_20171229_1.pdf
56,2018-01-03,大参林2018年第一次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2018-01-03/603233_20180103_1.pdf
57,2018-01-03,大参林2018年第一次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2018-01-03/603233_20180103_2.pdf
58,2018-01-06,大参林关于使用部分闲置募集资金购买理财产品的进展公告,/disclosure/listedinfo/announcement/c/2018-01-06/603233_20180106_1.pdf
59,2018-01-19,大参林关于使用闲置自有资金购买理财产品的进展公告,/disclosure/listedinfo/announcement/c/2018-01-19/603233_20180119_2.pdf
60,2018-01-19,大参林关于使用部分闲置募集资金购买理财产品的进展公告,/disclosure/listedinfo/announcement/c/2018-01-19/603233_20180119_1.pdf
61,2018-01-26,大参林关于使用闲置自有资金购买理财产品的进展公告,/disclosure/listedinfo/announcement/c/2018-01-26/603233_20180126_2.pdf
62,2018-01-26,大参林关于使用闲置募集资金购买理财产品的进展公告,/disclosure/listedinfo/announcement/c/2018-01-26/603233_20180126_1.pdf
63,2018-02-06,大参林关于使用闲置自有资金购买理财产品的进展公告,/disclosure/listedinfo/announcement/c/2018-02-06/603233_20180206_1.pdf
64,2018-02-06,大参林关于使用闲置募集资金购买理财产品的进展公告,/disclosure/listedinfo/announcement/c/2018-02-06/603233_20180206_2.pdf
65,2018-02-09,大参林第二届监事会第九次会议决议的公告,/disclosure/listedinfo/announcement/c/2018-02-09/603233_20180209_2.pdf
66,2018-02-09,大参林第二届董事会第十五次会议决议公告,/disclosure/listedinfo/announcement/c/2018-02-09/603233_20180209_1.pdf
67,2018-02-14,大参林关于变更持续督导保荐代表人的公告,/disclosure/listedinfo/announcement/c/2018-02-14/603233_20180214_1.pdf
